Johnson & Johnson [NYSE: JNJ] jumped around 9189847.59 points on Monday, while shares priced at $9190000.0 at the close of the session, up 0.22%.
Johnson & Johnson stock is now 4.04% up from its year-to-date (YTD) trading value. JNJ Stock saw the intraday high of $152.8914 and lowest of $151.52 per share. The company’s 52-week high price is 169.99, which means current price is +8.58% above from all time high which was touched on 03/04/25.
Compared to the average trading volume of 9.19M shares, JNJ reached a trading volume of 8913689 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Johnson & Johnson [JNJ]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JNJ shares is $170.84 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JNJ stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Johnson & Johnson shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on May 13, 2025. While these analysts kept the previous recommendation, BofA Securities raised their target price to Neutral. The new note on the price target was released on December 10, 2024, representing the official price target for Johnson & Johnson stock. Previously, the target price had yet another raise to $190, while Wolfe Research analysts kept a Outperform rating on JNJ stock. On July 23, 2024, analysts decreased their price target for JNJ shares from 160 to 150.
The Price to Book ratio for the last quarter was 4.70, with the Price to Cash per share for the same quarter was set at 16.12. Price to Free Cash Flow for JNJ in the course of the last twelve months was 18.04 with Quick ratio for the last quarter at 1.03.
How has JNJ stock performed recently?
Johnson & Johnson [JNJ] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.95. With this latest performance, JNJ shares dropped by -0.54% in over the last four-week period, additionally plugging by 4.73% over the last 6 months – not to mention a rise of 5.62% in the past year of trading.
Johnson & Johnson [JNJ]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Johnson & Johnson [JNJ] shares currently have an operating margin of 23.83% and a Gross Margin at 68.24%. Johnson & Johnson’s Net Margin is presently recorded at 24.41%.
Return on Equity for this stock inclined to 11.93%, with Return on Assets sitting at 11.93%.
Earnings analysis for Johnson & Johnson [JNJ]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JNJ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Johnson & Johnson go to 5.90%.
Insider trade positions for Johnson & Johnson [JNJ]
There are presently around $74.00%, or 74.04% of JNJ stock, in the hands of institutional investors. The top three institutional holders of JNJ stocks are: VANGUARD GROUP INC with ownership of 229.04 million shares, which is approximately 9.5164%. BLACKROCK INC., holding 198.19 million shares of the stock with an approximate value of $$28.97 billion in JNJ stocks shares; and BLACKROCK INC., currently with $$19.45 billion in JNJ stock with ownership which is approximately 5.5298%.
